Valuation : Ovation Science Inc.

Market Cap 1.15M 834K 717K 675K 616K 78.7M 1.16M 7.97M 3.09M 40.38M 3.13M 3.06M 130M P/E 2024
-2.68x
P/E 2025 -2.26x
Enterprise Value 1.36M 986K 848K 798K 729K 93.08M 1.37M 9.43M 3.66M 47.76M 3.7M 3.62M 154M EV / Sales 2024
13.2x
EV / Sales 2025 25.7x
Free-Float
76.56%
Yield 2024 *
-
Yield 2025 -
1 day-79.67%
1 month-79.67%
3 months-78.57%
6 months-64.62%
Current year-74.58%
Current year 0.01
Extreme 0.007
0.08
1 year 0.01
Extreme 0.007
0.08
3 years 0.01
Extreme 0.007
0.12
5 years 0
Extreme 0.0023
0.12
10 years 0
Extreme 0.0023
0.48
Manager TitleAgeSince
Director of Finance/CFO 63 29/10/2023
Chief Executive Officer 77 03/10/2017
Director TitleAgeSince
Director/Board Member 77 03/10/2017
Director/Board Member 63 03/10/2017
Director/Board Member 86 01/02/2018
Change 5-day change 1-year change 3-year change Capi.($)
-79.67%-.--% - - 834K
+1.43%-1.18%-5.07%-5.39% 238B
-2.58%-7.20%+11.96% - 45.7B
-2.96%-14.63%+81.15% - 10.95B
+0.61%-8.52%+41.59%-42.15% 8.82B
+0.56%-4.85%+20.72%+7.18% 6.57B
+2.10%+5.35%-17.99%-19.93% 6.47B
+2.35%-0.93%+1.94%-17.08% 3.74B
+0.51%+2.75%-22.93%-44.31% 3.68B
+0.36%-2.03%-4.73%-41.30% 2.86B
Average -7.73%-3.30%+11.85%-23.28% 36.26B
Weighted average by Cap. +0.69%-2.55%+1.62%-7.70%

Financials

2024 2025
Net sales 113K 81.83K 70.42K 66.25K 60.52K 7.73M 114K 783K 304K 3.96M 307K 301K 12.77M 67.89K 49.07K 42.22K 39.73K 36.29K 4.63M 68.07K 469K 182K 2.38M 184K 180K 7.66M
Net income -456K -330K -284K -267K -244K -31.13M -457K -3.15M -1.22M -15.97M -1.24M -1.21M -51.46M -631K -456K -393K -369K -337K -43.08M -633K -4.37M -1.69M -22.1M -1.71M -1.68M -71.2M
Net Debt 265K 192K 165K 155K 142K 18.1M 266K 1.83M 712K 9.28M 720K 704K 29.91M 211K 152K 131K 123K 113K 14.38M 211K 1.46M 566K 7.38M 572K 560K 23.77M
Logo Ovation Science Inc.
Ovation Science Inc. is a Canada-based drug development company. The Company develops topical and transdermal cannabidiol (CBD)/ tetrahydrocannabinol (THC) and other cannabinoid products which are out-licensed and also distributed under its own brands; ARLO CBD Beauty and InVibe MD (wellness line); all powered by its patented Invisicare skin delivery technology. The Company manufactures, distributes, sells, markets, sub-licenses and promotes products formulated with Invisicare, containing cannabinoids, hemp seed oil or synthetic derivatives of cannabis. The Company has developed topical and transdermal creams and lotions made with CBD, THC and combinations thereof plus hemp seed oil. Invisicare is a patented polymer-based technology for topical and transdermal skincare products. ARLO CBD Beauty offers science-based skincare solutions. Invibe MD offers a health and wellness product line infused with hemp-derived CBD and developed using Invisicare drug delivery technology.
Employees
-